Healthcare, Communication Jan 21, 2022 12:49 PM (GMT+8)
Recently, "lifeshield medical", which owns two wholly-owned subsidiaries of German enmodes GmbH and Suzhou feidun medical, recently announced that it had completed the financing of hundreds of millions of yuan. The current round of financing is led by PICC capital. The existing investors, bilingxing venture capital, continue to pursue the investment, and highlights capital, Junan holdings and Naxin capital follow the investment. The financing will be used for the R & D, production and human clinical trials of the company's new generation of in vivo interventional cardiac support system, in vitro carbon dioxide removal system (ECCO2R) for the treatment of severe COPD and ECMO in vitro membrane oxygenation system.
This text is a result of machine translation.